skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation

Journal Article · · Experimental Cell Research
 [1];  [1];  [2]; ; ;  [1];  [2];  [3]
  1. Transcriptome profiling group, National Institute of Radiological Sciences, Chiba (Japan)
  2. Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo (Japan)
  3. Department of Molecular Cell Biology, Medical Research Institute and School of Biomedical Science, Tokyo Medical and Dental University, Tokyo (Japan)

Mitogen-activated protein kinases (MAPKs) regulate proliferation and differentiation in osteoblasts. The vertebral homologue of nemo, nemo-like kinase (NLK), is an atypical MAPK that targets several signaling components, including the T-cell factor/lymphoid enhancer factor (TCF/Lef1) transcription factor. Recent studies have shown that NLK forms a complex with the histone H3-K9 methyltransferase SETDB1 and suppresses peroxisome proliferator-activated receptor (PPAR)-gamma:: action in the mesenchymal cell line ST2. Here we investigated whether NLK regulates osteoblastic differentiation. We showed that NLK mRNA is expressed in vivo in osteoblasts at embryonic day 18.5 (E18.5) mouse calvariae. By using retrovirus vectors, we performed forced expression of NLK in primary calvarial osteoblasts (pOB cells) and the mesenchymal cell line ST2. Wild-type NLK (NLK-WT) suppressed alkaline phosphatase activity and expression of bone marker genes such as alkaline phosphatase, type I procollagen, runx2, osterix, steopontin and osteocalcin in these cells. NLK-WT also decreased type I collagen protein expression in pOB and ST2 cells. Furthermore, mineralized nodule formation was reduced in pOB cells overexpressing NLK-WT. In contrast, kinase-negative form of NLK (NLK-KN) did not suppress or partially suppress ALP activity and bone marker gene expression in pOB and ST2 cells. NLK-KN did not suppress nodule formation in pOB cells. In addition to forced expression, suppression of endogenous NLK expression by siRNA increased bone marker gene expression in pOB and ST2 cells. Finally, transcriptional activity analysis of gene promoters revealed that NLK-WT suppressed Wnt1 activation of TOP flash promoter and Runx2 activation of the osteocalcin promoter. Taken together, these results suggest that NLK negatively regulates osteoblastic differentiation.

OSTI ID:
22212066
Journal Information:
Experimental Cell Research, Vol. 316, Issue 7; Other Information: Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English

Similar Records

MEK5 suppresses osteoblastic differentiation
Journal Article · Fri Jul 31 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:22212066

Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling
Journal Article · Fri Jun 03 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:22212066

L-type calcium channels play a crucial role in the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells
Journal Article · Fri Aug 03 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22212066